INTEGER INVESTMENTS

  • HOME

  • INVESTMENTS

    • INVESTMENT BELIEFS
    • INVESTMENT AREAS
  • TECHNOLOGY & SECURITY

  • TEAM

  • PERFORMANCE

    • PERFORMANCE
    • RISKS
    • FEES
  • RESEARCH

  • TOOLS

  • SUBSCRIBE

  • More

    Use tab to navigate through the menu items.
    Teva: Is It Cheap Enough?
    Integer Investments
    • Dec 30, 2016
    • 1 min

    Teva: Is It Cheap Enough?

    - The pharma industry has been slammed by political campaigns. - Within the pharma industry, generic drug companies offer investing opportunities. - TEVA trades at very low multiples. - Yet, we have some concerns about the management. To read the full article click here. #Pharmaceuticals #TEVA